impact factor, citescore
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER19423Switching from intravenous to subcutaneous infliximab in Behçet’s disease: feasibility, safety and early outcomes 20.00 €
 Subtotal 20.00 €